相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Treatment outcomes and safety in children with rifampicin-resistant TB
E. Lopez-Varela et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2022)
Moxifloxacin Pharmacokinetics, Cardiac Safety, and Dosing for the Treatment of Rifampicin-Resistant Tuberculosis in Children
Kendra K. Radtke et al.
CLINICAL INFECTIOUS DISEASES (2022)
Bedaquiline for multidrug-resistant TB in paediatric patients
R. Moodliar et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2021)
Implementing novel regimens for drug-resistant TB in South Africa: what can the world learn?
N. Ndjeka et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2020)
Pharmacokinetics, optimal dosing, and safety of linezolid in children with multidrug-resistant tuberculosis: Combined data from two prospective observational studies
Anthony J. Garcia-Prats et al.
PLOS MEDICINE (2019)
Inclusion of key populations in clinical trials of new antituberculosis treatments: Current barriers and recommendations for pregnant and lactating women, children, and HIV-infected persons
Amita Gupta et al.
PLOS MEDICINE (2019)
Re-Understanding the Mechanisms of Action of the Anti-Mycobacterial Drug Bedaquiline
Jickky Palmae Sarathy et al.
ANTIBIOTICS-BASEL (2019)
Relative bioavailability of bedaquiline tablets suspended in water: Implications for dosing in children
Elin M. Svensson et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
The burden of multidrug-resistant tuberculosis in children
H. E. Jenkins et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2018)
Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis: a retrospective cohort study
Kathryn Schnippel et al.
LANCET RESPIRATORY MEDICINE (2018)
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
Nafees Ahmad et al.
LANCET (2018)
Confirming model-predicted pharmacokinetic interactions between bedaquiline and lopinavir/ritonavir or nevirapine in patients with HIV and drug-resistant tuberculosis
Margreke J. E. Brill et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
Drug-drug interactions between bedaquiline and the antiretrovirals lopinavir/ritonavir and nevirapine in HIV-infected patients with drug-resistant TB
Mishal Pandie et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Population Pharmacokinetics of Bedaquiline and Metabolite M2 in Patients With Drug-Resistant Tuberculosis: The Effect of Time-Varying Weight and Albumin
E. M. Svensson et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2016)
Population Pharmacokinetics of Bedaquiline (TMC207), a Novel Antituberculosis Drug
Sarah C. McLeay et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Impact of Lopinavir-Ritonavir or Nevirapine on Bedaquiline Exposures and Potential Implications for Patients with Tuberculosis-HIV Coinfection
Elin M. Svensson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Bedaquiline: a review of human pharmacokinetics and drug-drug interactions
R. P. G. van Heeswijk et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline
Andreas H. Diacon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Model-Based Estimates of the Effects of Efavirenz on Bedaquiline Pharmacokinetics and Suggested Dose Adjustments for Patients Coinfected with HIV and Tuberculosis
Elin M. Svensson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Consensus Statement on Research Definitions for Drug-Resistant Tuberculosis in Children
James A. Seddon et al.
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2013)
Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects Models
Martin Bergstrand et al.
AAPS JOURNAL (2011)
Diarylquinolines target subunit c of mycobacterial ATP synthase
Anil Koul et al.
NATURE CHEMICAL BIOLOGY (2007)
PsN-Toolkit - A collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM
L Lindbom et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2005)
A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis
K Andries et al.
SCIENCE (2005)
分享论文
